Ottobock CEO outlines strategy. Ottobock stock falls 2.68 percent

Published on 10/20/2026 at 10:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Ottobock's first-half core revenue grew 6.70 percent. Ottobock stock costs EUR 50.80 on October 20, 2026 versus the EUR 52.20 Xetra close.

Strategy and calendar

Oliver Jakobi discussed Ottobock's first year as a listed company on October 19, 2026.
Ottobock reported 6.70 percent organic core revenue growth in the first half of 2026.
Ottobock stock trades at EUR 50.80 at 10:42 a.m. CEST at Lang & Schwarz on October 20, 2026, 2.68 percent below the Xetra close of October 19, 2026.

Ottobock, DE000BCK2223, Illustration mit AI erstellt.

Ottobock (ISIN DE000BCK2223) stock was trading at EUR 50.80 at Lang & Schwarz on October 20, 2026 at 10:42 a.m. CEST, down 2.68 percent versus the Xetra close of October 19, 2026 at EUR 52.20. In an interview published on October 19, 2026, CEO Oliver Jakobi said the company had improved growth and profitability, sharpened its portfolio and narrowed its 2026 forecast upward, according to Verlag Orthopädie-Technik.

Strategy shifts toward core care

The interview puts the operating strategy ahead of the daily quotation. Jakobi described investments in neuro-orthotics and functional electrical stimulation, alongside continued development of the Patient Care business. The company also sold Human Mobility to sharpen its portfolio, according to Verlag Orthopädie-Technik.

For the first half of 2026, Ottobock delivered 6.70 percent organic core revenue growth, while Patient Care grew 4.20 percent organically, according to Inderes. The figures give investors a clearer operating benchmark than the interview's qualitative description of improved profitability.

What changed across the year

Ottobock's recent chronology combines operating progress, analyst support and a sharper market reaction. On August 13, 2026, first-half organic core revenue growth stood at 6.70 percent, according to Inderes. On September 15, 2026, Jefferies maintained a Buy rating and an EUR 83.00 price target, according to MarketScreener. On October 19, 2026, Jakobi outlined the strategy while the stock later closed on Xetra at EUR 52.20.

Which dates matter next

Ottobock's investor-relations calendar lists the Q3 2026 quarterly statement for November 12, 2026, followed by the BNP Paribas MidCap CEO Conference on November 16, 2026, on the company's Ottobock investor page. Those dates give the market two near-term checks on the narrowed 2026 outlook and the strategy described by management.

Stock reaction and investor frame

The October 20 quotation leaves the stock EUR 1.40 below the previous Xetra close, a 2.68 percent decline. The move places the immediate emphasis on whether operating growth and portfolio discipline can outweigh concerns reflected in the recent share-price weakness.

The stock was trading at EUR 50.80 at Lang & Schwarz on October 20, 2026 at 10:42 a.m. CEST, 2.68 percent below the Xetra close of October 19, 2026 at EUR 52.20. The further course of trading is shown by the continuously updated real-time quote of Ottobock stock.